vs

Side-by-side financial comparison of biote Corp. (BTMD) and MEDALLION FINANCIAL CORP (MFIN). Click either name above to swap in a different company.

MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $46.4M, roughly 1.5× biote Corp.). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs 4.2%, a 13.1% gap on every dollar of revenue. On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs -6.9%). Over the past eight quarters, MEDALLION FINANCIAL CORP's revenue compounded faster (15.0% CAGR vs -0.4%).

biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.

Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.

BTMD vs MFIN — Head-to-Head

Bigger by revenue
MFIN
MFIN
1.5× larger
MFIN
$70.6M
$46.4M
BTMD
Growing faster (revenue YoY)
MFIN
MFIN
+32.3% gap
MFIN
25.4%
-6.9%
BTMD
Higher net margin
MFIN
MFIN
13.1% more per $
MFIN
17.3%
4.2%
BTMD
Faster 2-yr revenue CAGR
MFIN
MFIN
Annualised
MFIN
15.0%
-0.4%
BTMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTMD
BTMD
MFIN
MFIN
Revenue
$46.4M
$70.6M
Net Profit
$2.0M
$12.2M
Gross Margin
Operating Margin
14.7%
29.3%
Net Margin
4.2%
17.3%
Revenue YoY
-6.9%
25.4%
Net Profit YoY
-47.2%
20.3%
EPS (diluted)
$0.05
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTMD
BTMD
MFIN
MFIN
Q4 25
$46.4M
$70.6M
Q3 25
$48.0M
$58.7M
Q2 25
$48.9M
$62.6M
Q1 25
$49.0M
$63.0M
Q4 24
$49.8M
$56.3M
Q3 24
$51.4M
$53.3M
Q2 24
$49.2M
$51.0M
Q1 24
$46.8M
$53.3M
Net Profit
BTMD
BTMD
MFIN
MFIN
Q4 25
$2.0M
$12.2M
Q3 25
$8.2M
$7.8M
Q2 25
$3.2M
$11.1M
Q1 25
$13.7M
$12.0M
Q4 24
$3.7M
$10.1M
Q3 24
$10.7M
$8.6M
Q2 24
$-7.1M
$7.1M
Q1 24
$-4.2M
$10.0M
Operating Margin
BTMD
BTMD
MFIN
MFIN
Q4 25
14.7%
29.3%
Q3 25
17.2%
33.2%
Q2 25
22.0%
31.1%
Q1 25
19.8%
32.1%
Q4 24
5.6%
32.8%
Q3 24
23.7%
26.6%
Q2 24
12.7%
24.3%
Q1 24
22.3%
33.6%
Net Margin
BTMD
BTMD
MFIN
MFIN
Q4 25
4.2%
17.3%
Q3 25
17.1%
13.2%
Q2 25
6.5%
17.7%
Q1 25
28.0%
19.1%
Q4 24
7.4%
18.0%
Q3 24
20.8%
16.1%
Q2 24
-14.4%
13.9%
Q1 24
-8.9%
18.8%
EPS (diluted)
BTMD
BTMD
MFIN
MFIN
Q4 25
$0.05
$0.50
Q3 25
$0.22
$0.32
Q2 25
$0.10
$0.46
Q1 25
$0.37
$0.50
Q4 24
$0.09
$0.43
Q3 24
$0.33
$0.37
Q2 24
$-0.21
$0.30
Q1 24
$-0.12
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTMD
BTMD
MFIN
MFIN
Cash + ST InvestmentsLiquidity on hand
$24.1M
$136.3M
Total DebtLower is stronger
$103.1M
$216.0M
Stockholders' EquityBook value
$-58.5M
$408.6M
Total Assets
$107.6M
$3.0B
Debt / EquityLower = less leverage
0.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTMD
BTMD
MFIN
MFIN
Q4 25
$24.1M
$136.3M
Q3 25
$28.0M
$72.5M
Q2 25
$19.6M
$110.4M
Q1 25
$41.7M
$131.5M
Q4 24
$39.3M
$98.2M
Q3 24
$38.2M
$120.6M
Q2 24
$26.4M
$87.7M
Q1 24
$78.8M
$54.8M
Total Debt
BTMD
BTMD
MFIN
MFIN
Q4 25
$103.1M
$216.0M
Q3 25
$104.7M
$215.7M
Q2 25
$106.3M
$199.9M
Q1 25
$107.8M
$199.7M
Q4 24
$109.4M
$232.2M
Q3 24
$110.9M
$232.0M
Q2 24
$112.5M
$230.8M
Q1 24
$114.1M
$225.6M
Stockholders' Equity
BTMD
BTMD
MFIN
MFIN
Q4 25
$-58.5M
$408.6M
Q3 25
$-72.8M
$397.4M
Q2 25
$-85.1M
$389.9M
Q1 25
$-90.0M
$380.2M
Q4 24
$-105.9M
$370.2M
Q3 24
$-130.3M
$362.4M
Q2 24
$-143.2M
$354.0M
Q1 24
$-36.0M
$349.0M
Total Assets
BTMD
BTMD
MFIN
MFIN
Q4 25
$107.6M
$3.0B
Q3 25
$111.3M
$2.9B
Q2 25
$104.8M
$2.9B
Q1 25
$123.4M
$2.8B
Q4 24
$122.4M
$2.9B
Q3 24
$101.3M
$2.9B
Q2 24
$92.9M
$2.8B
Q1 24
$160.1M
$2.6B
Debt / Equity
BTMD
BTMD
MFIN
MFIN
Q4 25
0.53×
Q3 25
0.54×
Q2 25
0.51×
Q1 25
0.53×
Q4 24
0.63×
Q3 24
0.64×
Q2 24
0.65×
Q1 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTMD
BTMD
MFIN
MFIN
Operating Cash FlowLast quarter
$7.6M
$126.3M
Free Cash FlowOCF − Capex
$6.5M
FCF MarginFCF / Revenue
14.0%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
3.87×
10.35×
TTM Free Cash FlowTrailing 4 quarters
$30.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTMD
BTMD
MFIN
MFIN
Q4 25
$7.6M
$126.3M
Q3 25
$14.1M
$67.0M
Q2 25
$7.1M
$-10.7M
Q1 25
$6.5M
$36.3M
Q4 24
$12.4M
$108.7M
Q3 24
$15.6M
$24.6M
Q2 24
$9.9M
$27.6M
Q1 24
$7.4M
$32.3M
Free Cash Flow
BTMD
BTMD
MFIN
MFIN
Q4 25
$6.5M
Q3 25
$13.6M
Q2 25
$5.3M
Q1 25
$4.8M
Q4 24
$10.7M
Q3 24
$14.0M
Q2 24
$7.4M
Q1 24
$6.7M
FCF Margin
BTMD
BTMD
MFIN
MFIN
Q4 25
14.0%
Q3 25
28.3%
Q2 25
10.8%
Q1 25
9.9%
Q4 24
21.5%
Q3 24
27.3%
Q2 24
15.1%
Q1 24
14.2%
Capex Intensity
BTMD
BTMD
MFIN
MFIN
Q4 25
2.3%
Q3 25
1.0%
Q2 25
3.7%
Q1 25
3.3%
Q4 24
3.4%
Q3 24
3.0%
Q2 24
5.1%
Q1 24
1.5%
Cash Conversion
BTMD
BTMD
MFIN
MFIN
Q4 25
3.87×
10.35×
Q3 25
1.72×
8.63×
Q2 25
2.22×
-0.97×
Q1 25
0.47×
3.02×
Q4 24
3.34×
10.72×
Q3 24
1.45×
2.86×
Q2 24
3.89×
Q1 24
3.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTMD
BTMD

Product Revenue$45.3M98%
Disposable Trocars Product Revenue$1.2M3%

MFIN
MFIN

Segment breakdown not available.

Related Comparisons